I-Mab to Participate at the Piper Sandler Healthcare Conference
I-Mab to Participate at the Piper Sandler Healthcare Conference
The 36th Annual Healthcare Conference will be held in New York, December 3-5, 2024
第36届年度医疗会议将于2024年12月3日至5日在纽约举行
ROCKVILLE, Md., Nov. 21, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB, the "Company"), a U.S.-based global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024.
马里兰州罗克维尔，2024年11月21日 /PRNewswire/ -- 天境生物（纳斯达克：IMAb，"公司"）是一家总部位于美国的全球生物科技公司，专注于开发高度差异化的免疫疗法用于癌症治疗，今天宣布管理层将于2024年12月4日在派杰投资第36届年度医疗会议上进行演讲。
Piper Sandler 36th Annual Healthcare Conference Presentation Details
派杰投资第36届年度医疗会议演讲详情
|
Presentation Time |
Wednesday, December 4 at 4:30 p.m. ET |
|
Presenters |
Sean Fu, PhD, MBA, Chief Executive Officer Phillip Dennis, MD, PhD, Chief Medical Officer |
|
Webcast link |
Here |
|
Meetings |
One-on-one and small group meetings: December 3 – 4, 2024 |
|
Management |
Sean Fu, PhD, MBA, Chief Executive Officer Joseph Skelton, Chief Financial Officer Phillip Dennis, MD, PhD, Chief Medical Officer Tyler Ehler, Senior Director, Investor Relations |
|
演讲时间 |
时间：12月4日星期三，东部时间下午4:30 |
|
演讲人 |
Sean Fu，博士，MBA，首席执行官 Phillip Dennis，医学博士，博士，首席医疗官 |
|
网络视频链接 |
这里 |
|
会议 |
一对一和小组会议：2024年12月3日至4日 |
|
管理 |
Sean Fu，博士，MBA，首席执行官 Joseph Skelton，首席财务官 Phillip Dennis，医学博士，博士，首席医疗官 高级董事Tyler Ehler投资者关系 |
The webcast will also be available under "Event Calendar" on I-Mab's IR website
at
网络视频链接可在I-Mab的IR网站的"活动日历"中找到。
电话
For more information, please contact your Piper Sandler representative.
如需更多信息，请联系您的派杰投资代表。
About I-Mab
关于天境生物
I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit and follow us on LinkedIn and X.
天境生物(纳斯达克: IMAB)是一家总部位于美国的全球生物科技公司，专注于开发高度差异化的免疫疗法用于癌症治疗。天境生物在马里兰州的罗克维尔和新泽西州的短山建立了运营中心。有关更多信息，请访问并关注我们在LinkedIn和X上的动态。
For more information, please contact:
更多信息，请联系:
Tyler Ehler
Senior Director, Investor Relations
[email protected]
泰勒·埃勒
投资者关系高级总监
[email protected]
SOURCE I-Mab Biopharma
来源：天境生物医药
